(MENAFN - GetNews)According to new report available with Million Insights, the global veterinary vaccines industry report on is foretold to provide a robust support for market players to lay a solid foundation for their business growth. It includes a comprehensive evaluation of the market's growth status and market risk.

Global Veterinary/Animal Vaccines Market is expected to reach USD 12.6 billion by 2025. Vaccine administration is a process that increases the resistant or immune power to an infectious disease. The aim of veterinary/animal vaccines is to recover the welfare and health of companion animals, prevent the transmission of diseases from animals to human from wildlife as well as domestic animals, and cost-efficiently rise the production of livestock. The vaccines may be administered via oral or parenteral routes. The Veterinary Vaccines Market is estimated to grow at a significant CAGR over the forecast period as the scope and its applications are rising enormously across the globe.

Growing livestock population, rise in breakouts of livestock diseases, increasing zoonotic diseases, increasing initiative by government agencies, and growing number of key players are documented as major factors of Veterinary/Animal Vaccines industry that are estimated to enhance the growth in the years to come. However, high cost of vaccine and its storage are the factor that may restrain overall market growth in the coming years. Animal Vaccines Market is segmented based on type, disease type, technology, and region.

To download the sample pdf of Veterinary/Animal Vaccines Market Report ''Please” click here:

Aquaculture Vaccines, Porcine Vaccines, Companion Animal Vaccines, Poultry Vaccines, Livestock Vaccines, and other types could be explored in Veterinary/Animal Vaccines in the forecast period. Livestock vaccines include Small Ruminant Vaccines and Bovine Vaccines. On the other hand, companion animal vaccines include Feline Vaccines and Canine Vaccines.

The porcine vaccines sector accounted for the largest market share of Veterinary/Animal Vaccines in terms of value. In addition, Companion Animal Vaccines sector is estimated to grow at fastest pace in the coming years. This may be because of growing awareness regarding companion animal vaccination, increasing number of pet and pet ownership, and growing occurrence of zoonotic diseases in humans.

Aquaculture Diseases, Porcine Diseases, Companion Animal Diseases, Poultry Diseases, Livestock Diseases, and others are the diseases that could be explored in Veterinary/Animal Vaccines in the forecast period. The porcine sector accounted for the substantial market share and is estimated to lead the overall market in the coming years.

The enhanced technology includes Recombinant Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Inactivated Vaccines, and others that could be explored in the forecast period. The live attenuated vaccines sector accounted for the substantial market share of Veterinary/Animal Vaccines and is estimated to continue its dominance in the coming years. This may be because it offers long-term immunity and can be administered easily.

Globally, Europe is accounted for the substantial market share of Veterinary/Animal Vaccines in terms of revenue and is estimated to lead the overall market in the coming years. The reason behind the overall market growth could be rising use of enhanced technology and presence of key manufacturers in the region. Instead, North America and the Asia Pacific are also estimated to have a positive influence on the future growth.

North America is the second largest region with significant market share. However, Asia Pacific is estimated to grow at fastest pace with the highest CAGR in the foremost period. The aspects that may be ascribed to the growth comprise growing investment in vaccine manufacturing services in developing countries, growing pet adoption, and development of key manufacturers in the region.

The key players of Veterinary/Animal Vaccines Market are Virbac, Zoetis, Phibro Animal Health, Merck Animal Health, Ceva, Elanco, and BoehringerIngelheim. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As companies all over the world have to believe that alliance with a market would permit them proportional market existence and authority to declare the leadership position.

To browse report summary & detailed TOC, please click the link below:

Market Segment:

Product Outlook (Revenue, USD Million, 2014 – 2025)
    • Attenuated Live Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • DNA Vaccines
    • Recombinant Vaccines

Animal Type Outlook (Revenue, USD Million, 2014 – 2025)
    • Companion Animal Vaccines.
        • Canine
            • Distemper
            • Kennel cough (Parainfluenza)
            • Parvovirus
            • Canine herpes
            • Lyme Disease
        • Feline
            • Feline calicivirus
            • Peritonitis (FIP)
            • Feline FIV
    • Cattle Vaccines
        • BRSV
        • Enzootic Bronchopneu
        • IBR
        • BVD/MD
    • Poultry Vaccines
        • Bronchitis
        • Avian Influenza
        • Marek’s Disease
        • Newcastle Disease
    • Pig Vaccines
        • Porcine reproductive disease
        • Swine Influenza
        • Swine Pneumonia
    • Equine Vaccines
        • Encephalomyelitis
        • Rhinopneumonitis
        • Influenza (Horse Flu)

Regional Outlook (Revenue, USD Million, 2014 – 2025)
    • North America
        • U.S.
        • Canada
    • Europe
        • U.K.
        • Germany
    • Asia Pacific
         • India
        • China
    • Latin America
        • Brazil
        • Mexico
    • Middle East & Africa
        • South Africa

Browse the Latest Press Releases Available with Million Insights:

Pre-engineered Building Market – The global pre-engineered building market size is projected to reach USD 30.79 billion by 2025 with a CAGR of 15.5%. Rising technological developments in the construction industry and growing urbanization & industrialization in the developing economies such as China, Brazil and India are expected to drive the demand for the market.

Plant Genotyping Equipment Market  –  The global plant genotyping equipment market size is anticipated to value USD 895.45 million until 2025. It is also expected to register a CAGR of 9.6% over the forecasted years, 2018 to 2025. The increasing need for identifying, assessing and validating genetic markers of plants to gain higher yield from them is driving the market growth for plant genotyping equipments.

About Million Insights
Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.


Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Source link